US20100104655A1 - Therapeutic Polymeric Nanoparticles Comprising Vinca Alkaloids and Methods of Making and Using Same - Google Patents

Therapeutic Polymeric Nanoparticles Comprising Vinca Alkaloids and Methods of Making and Using Same Download PDF

Info

Publication number
US20100104655A1
US20100104655A1 US12/485,467 US48546709A US2010104655A1 US 20100104655 A1 US20100104655 A1 US 20100104655A1 US 48546709 A US48546709 A US 48546709A US 2010104655 A1 US2010104655 A1 US 2010104655A1
Authority
US
United States
Prior art keywords
poly
acid
lactic
therapeutic nanoparticle
ethylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US12/485,467
Other versions
US8318211B2 (en
Inventor
Stephen E. Zale
Greg Troiano
Mir Mukkaram Ali
Jeff Hrkach
James Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
BIND Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US6170408P priority Critical
Priority to US6169708P priority
Priority to US6176008P priority
Priority to US8815908P priority
Priority to US10591608P priority
Priority to US10677708P priority
Priority to US16954109P priority
Priority to US16951909P priority
Priority to US16951409P priority
Priority to US17378409P priority
Priority to US17521909P priority
Priority to US17522609P priority
Priority to US17520909P priority
Priority to US18230009P priority
Priority to US12/485,467 priority patent/US8318211B2/en
Application filed by BIND Biosciences Inc filed Critical BIND Biosciences Inc
Assigned to BIND BIOSCIENCES, INC. reassignment BIND BIOSCIENCES, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: WRIGHT, JAMES, ALI, MIR MUKKARAM, HRKACH, JEFF, TROIANO, GREG, ZALE, STEPHEN E.
Publication of US20100104655A1 publication Critical patent/US20100104655A1/en
Application granted granted Critical
Publication of US8318211B2 publication Critical patent/US8318211B2/en
Assigned to BIND THERAPEUTICS, INC. reassignment BIND THERAPEUTICS, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: BIND BIOSCIENCES, INC.
Assigned to PFIZER INC. reassignment PFIZER INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BIND THERAPEUTICS, INC.
Application status is Active legal-status Critical
Adjusted expiration legal-status Critical

Links